Screening Tool for Depresion in Cancer Pain Patients Clinical Trial
Official title:
The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients
Verified date | July 2022 |
Source | Mahidol University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Compare Thai versions of the Edmonton Symptom Assessment System (ESAS) and the Hospiral Anxiety and Depression Scale (HADS) with Diagnostic and Statistical Manual (DSM-5), as a screening tool for depression in cancer pain patients
Status | Completed |
Enrollment | 49 |
Est. completion date | January 31, 2020 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Cancer patients who follow up as out patient at pain clinic, Siriraj hospital - Age older than 18 years old - Fluently read, write and speak in Thai language - No cognitive impairment Exclusion Criteria: - Unstable clinical presentation - Severe pain or pain numerical rating scale more than 7 - Severe associated symptoms such as nausea, vomiting - The patient who do not know their diagnosis |
Country | Name | City | State |
---|---|---|---|
Thailand | Faculty of medicine Siriraj Hospital Mahidol University | Bangkoknoi | Bangkok |
Lead Sponsor | Collaborator |
---|---|
Mahidol University |
Thailand,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reliability and validity of Thai version of ESAS | Cut-off point, sensitivity, specificity, positive predictive value and negative predictive value of Thai version of ESAS | 1 year | |
Secondary | Correlation of Thai version of ESAS, HADS and DSM-5 | Pearson correlation, Sperman rank correlation | 1 year | |
Secondary | Internal consistency of Thai version of ESAS and HADS | Cronbach's alpha | 1 year |